| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/04/1999 | CN1044478C Quillaja saponin adjuvant and vaccine formulation containing same |
| 08/04/1999 | CN1044473C Tropone-substituted phenyloxazolidinone antibacterial agents |
| 08/03/1999 | US5932715 Nucleotide sequences encoding a CS2 pilin protein |
| 08/03/1999 | US5932706 Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 08/03/1999 | US5932705 Pasteurella haemolytica culturing to produce secreted polypeptides, fractionating peptides by molecular weight, identifying and purifying antigen |
| 08/03/1999 | US5932703 The present invention provides purified and isolated polynucleotide sequences encoding a novel human macrophage-derived c--c chemokine designated mdc, and polypeptide analogs thereof. |
| 08/03/1999 | US5932701 ribA |
| 08/03/1999 | US5932692 Antigenic peptides |
| 08/03/1999 | US5932540 Vascular endothelial growth factor 2 |
| 08/03/1999 | US5932476 Cloning of chicken anemia virus DNA |
| 08/03/1999 | US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 08/03/1999 | US5932461 Seryl tRNA synthetase from Staphylococcus aureus |
| 08/03/1999 | US5932448 Bispecific antibody heterodimers |
| 08/03/1999 | US5932446 Hmvab41 |
| 08/03/1999 | US5932445 Signal peptide-containing proteins |
| 08/03/1999 | US5932427 In vitro assay system for identifying compositions useful for stimulating B cells |
| 08/03/1999 | US5932426 Molecular presenting system |
| 08/03/1999 | US5932423 Cyclic nucleotide phosphodiesterases |
| 08/03/1999 | US5932225 Vaccine comprising eimeria spp. gametocyte antigen |
| 08/03/1999 | US5932224 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 08/03/1999 | US5932223 Rotavirus vaccine formulations |
| 08/03/1999 | US5932222 Mutant respiratory syncytial virus (RSV), vaccines containing same and methods of use |
| 08/03/1999 | US5932220 Lyme disease; using a peptide |
| 08/03/1999 | US5932219 Polypeptides |
| 08/03/1999 | US5932218 Multideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1 |
| 08/03/1999 | US5932217 Peptides which inhibit adhesion between leukocytes and endothelial cells |
| 08/03/1999 | US5932215 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema |
| 08/03/1999 | US5932212 Crosslinked protein crystal formulations and their use as catalysts in organic solvents |
| 08/03/1999 | CA1340692C Method of potentiating an immune response and compositions therefor |
| 07/29/1999 | WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | WO1999037797A1 Antigen-specific cells, methods of generating these cells and uses thereof |
| 07/29/1999 | WO1999037791A1 Multipurpose antibody derivatives |
| 07/29/1999 | WO1999037790A1 Human calcineurin b-like protein |
| 07/29/1999 | WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | WO1999037784A1 Porcine reproductive and respiratory syndrome oral vaccine production in plants |
| 07/29/1999 | WO1999037783A2 Live vaccine against brucellosis |
| 07/29/1999 | WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
| 07/29/1999 | WO1999037778A2 Compositions and methods for detecting and treating prostate cancer |
| 07/29/1999 | WO1999037777A2 Differentiation-associated sequences and methods of use therefor |
| 07/29/1999 | WO1999037775A2 Compositions and methods for detecting and treating breast cancer |
| 07/29/1999 | WO1999037774A2 Differentiation-associated sequences and methods of use therefor |
| 07/29/1999 | WO1999037759A2 Live attenuated salmonella vaccine |
| 07/29/1999 | WO1999037684A1 Antibodies to death receptor 4 (dr4) and uses thereof |
| 07/29/1999 | WO1999037683A1 MONOCLONAL ANTIBODY ANTI αv-INTEGRIN AND ITS USE TO INHIBIT αvβ6-INTEGRIN ATTACHMENT TO FIBRONECTIN |
| 07/29/1999 | WO1999037682A2 Antibodies against human il-12 |
| 07/29/1999 | WO1999037675A1 Nucleic acid sequences encoding capsaicin receptors |
| 07/29/1999 | WO1999037329A1 Pharmaceutical formulation comprising an antibody and a citrate buffer |
| 07/29/1999 | WO1999037327A1 A virus vaccine of enhanced immunogenicity against aujeszky's disease |
| 07/29/1999 | WO1999037326A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | WO1999037319A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | WO1999037317A1 Artificial proteoglycans |
| 07/29/1999 | WO1999037315A1 Chemical derivatives of autoantigens and autoimmune-suppressive peptides and pharmaceutical composition containing the same |
| 07/29/1999 | WO1999037313A1 Immune effector cell hybrids |
| 07/29/1999 | WO1999020755A3 Novel cytokine receptors |
| 07/29/1999 | WO1999019476A3 NON-MAMMALIAN MESODERM INDUCTION EARLY RESPONSE (nm-MIER) GENE FAMILY |
| 07/29/1999 | WO1998059063A3 Bovine adenovirus type 3 genome |
| 07/29/1999 | WO1995030750A8 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/29/1999 | DE19753176A1 New non-recombinant sub-unit vaccine useful for protecting patients against bacterial infection |
| 07/29/1999 | CA2319160A1 Monoclonal antibody anti .alpha.v-integrin and its use to inhibit .alpha.v.beta.6-integrin attachment to fibronectin |
| 07/29/1999 | CA2319141A1 Porcine reproductive and respiratory syndrome oral vaccine production in plants |
| 07/29/1999 | CA2319113A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | CA2319076A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
| 07/29/1999 | CA2318987A1 Immune effector cell hybrids |
| 07/29/1999 | CA2318979A1 Antigen-specific cells, methods of generating these cells and uses thereof |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318405A1 Antibodies to death receptor 4(dr4) and uses thereof |
| 07/29/1999 | CA2318352A1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | CA2318263A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | CA2317920A1 Human calcineurin b-like protein |
| 07/29/1999 | CA2317727A1 Multipurpose antibody derivatives |
| 07/28/1999 | EP0931793A1 Monoclonal antibody specific for the activated coagulation factor VII (FVIIa) and its use |
| 07/28/1999 | EP0931551A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 07/28/1999 | EP0931156A2 Gene expression and delivery systems and uses |
| 07/28/1999 | EP0931149A2 A novel haemopoietin receptor and genetic sequences encoding same |
| 07/28/1999 | EP0931147A1 ANTI-ErbB2 ANTIBODIES |
| 07/28/1999 | EP0931144A1 Novel human phospholemman-like protein |
| 07/28/1999 | EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 07/28/1999 | EP0931093A1 Helicobacter pylori live vaccine |
| 07/28/1999 | EP0930895A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones |
| 07/28/1999 | EP0930894A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 07/28/1999 | EP0930893A1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 07/28/1999 | EP0930892A1 Cytokine enhanced immunotherapy for brain tumors |
| 07/28/1999 | EP0930891A1 Oral administration of chicken yolk antibodies to treat disease |
| 07/28/1999 | EP0930890A1 USE OF FasL OR FasL TRANSFECTED CD4?+ /FasL?- /TH1-CELL LINES FOR THE TREATMENT OF TH1/TH2 DISEASES |
| 07/28/1999 | EP0930887A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/28/1999 | CN1224462A Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 07/27/1999 | US5929222 Expression of a foamy virus envelope protein |
| 07/27/1999 | US5929220 Hepadnavirus receptor |
| 07/27/1999 | US5929213 Antibodies to growth differentiation factor-12 |
| 07/27/1999 | US5929212 CD3 specific recombinant antibody |
| 07/27/1999 | US5929045 Screening for bactericides |
| 07/27/1999 | US5928939 Genetic engineering |
| 07/27/1999 | US5928928 For diagnosis of infections; for fungicides, antiprotozoa agents, antihelminthic agents; in body lotions, dentrifices, foods; for temporary implants; time-release agents |
| 07/27/1999 | US5928920 Amino acid sequence of enzyme which catalyzes addition of threonyl to transfer ribonucleic acid; for bacteristats and bactericides |
| 07/27/1999 | US5928917 A conjugate of nonprotein selected from tag, antibiotic, fungicide, insecticide and texturing agent joined to a nonfusion polypeptide having amino acid sequence coprising a substrate binding region of cellulase binds with 1,4-glucan |
| 07/27/1999 | US5928913 Herpes virus amplicon coding for antigen or immunomodulatory protein with replication-deficient helper herpes virus; for gene therapy and vaccines |
| 07/27/1999 | US5928902 Hybrid protein between CS from plasmodium and HBsAg |
| 07/27/1999 | US5928901 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum in hepatocytes and compositions containing them |